Radar · Dermatology in United States
Best Dermatology Companies in United States
The 390 best Dermatology companies in United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Incyte.
By Riya SenguptaFinancials
390companies tracked
$7.4Bdisclosed funding
0unicorns
184have raised
Ranking the top Dermatology companies across the United States by disclosed equity funding and recent funding momentum, this directory tracks 390 ventures carrying $7.4B in total disclosed capital. That's real money. The global dermatology market sits at roughly $1.1B today and is forecast to reach $2.8B by 2034 at a 6.9% CAGR, driven by immunological pathway research and growing precision medicine adoption. Evommune leads our funding table at $268M, followed by Rani Therapeutics at $234M. No unicorns yet, but the appetite from investors like OrbiMed, Arch Venture Partners, and Aisling Capital signals this sector isn't cooling.
The revenue picture is what I find more telling, honestly. Across 8 validated filers, median revenue runs $26M with 22% YoY growth, and the combined pool clears $470M. Medicis Pharmaceutical Corp posted $202M in revenue, up 22%, and Cynosure Inc added $122M at 19% growth. So who's winning on the bottom line? Apyx Medical Corp's net income hit 46x the sector median, a figure that stops you cold. Dermatological advances in medical skin treatments and clinical care are expanding fast, and the companies you'll find here are positioned directly in that current.
Ranked: Best Dermatology companies in United States
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Incyte Developer of small molecules for the treatment of different cancer and skin diseases | $750M | 151 mo ago | 1,387 | Herve Hoppenot Chairman and CEO | DrupalApple iCloud MailPHP+22 | 29 signals ▼59% Leadership · Earnings · Contracts | 7,097 patents Small-molecule kinase inhibitors and formulations for JAK/TYK, PI3K, and related therapies | 2 awards |
| 2 | Alumis Developer of therapeutics for the treatment of auto-immune disease | $529M | 23 mo ago | 16 | Martin Babler CEO | DrupalApple iCloud MailMicrosoft 365+21 | 10 signals ▼41% Earnings · IPO · Announcements | 88 patents TYK2 kinase inhibitor compounds and formulations for inflammatory disease treatment. | — |
| 3 | Evommune Developer of therapeutic options for chronic inflammatory disorders 60Growth top 16%Funding top 18%News top 25%Tech top 47% All 10 signals ▾Growthtop 16% Fundingtop 18% Newstop 25% Techtop 47% Fin. healthtop 47% Moattop 47% Patentsbottom 47% Marketbottom 46% Innovationbottom 42% Globalbottom 39% Growth: Revenue +86% YoY · Fresh capital in last 24 mo Funding: Raised $268M across 6 rounds · 6 rounds over 6 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 60/100 | $268M | 4 mo ago | 33 | — | WordPressMySQLPHP+20 | 15 signals ▲650% IPO · Earnings · M&A | 3 patents Small-molecule PKCθ inhibitors for immune‑modulating therapeutics | 2 launchs · 1 partnership |
| 4 | Rani Therapeutics Developer of technology for the oral delivery of large drug molecules 72Growth top 22%Funding top 23%Patents top 24%Talent top 27% All 11 signals ▾Growthtop 22% Fundingtop 23% Patentstop 24% Talenttop 27% Innovationtop 28% Newstop 30% Moattop 35% Techtop 45% Marketbottom 49% Fin. healthbottom 44% Globalbottom 42% Growth: Revenue +59% YoY · Fresh capital in last 24 mo Funding: Raised $234M across 6 rounds · 6 rounds over 13 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 72/100 | $234M | 7 mo ago | 163 | Mir Imran Founder | DrupalPHPZURB Foundation+25 | 16 signals ▲167% Leadership · Earnings · Funding | 456 patents Oral ingestible devices for delivering biologic therapeutics to the gastrointestinal tract | 1 launch |
| 5 | Cutera Developer of energy-based medical aesthetic devices for the treatment of multiple diseases | $225M | 42 mo ago | 540 540 → 542 (+0%) | David Mowry Founder & CEO | DrupalApple iCloud MailPHP+24 | — | 99 patents Advanced laser dermatology devices for precise skin lesion and tissue treatment | 1 launch |
| 6 | Third Harmonic Bio Developer therapeutics to treat allergy and inflammatory diseases | $205M | 52 mo ago | 28 | Natalie Holles Chief Executive Officer | WordPressApple iCloud MailMicrosoft 365+17 | — | — | — |
| 7 | DICE Developer of small molecule therapeutics for multiple disorders | $192M | 57 mo ago | 90 | — | — | — | 36 patents Video surveillance analytics and network communication protocol technologies | — |
| 8 | Dermiria Topical products to treat psoriasis, hyperhidrosis, and acne. | $162M | 89 mo ago | 4 | Thomas Wiggans CEO | — | — | — | — |
| 9 | Dermavant Developer of small molecule based therapeutics for the treatment of inflammatory skin diseases | $160M | 60 mo ago | 73 | Todd Zavodnick CEO | WordPressApple iCloud MailMicrosoft 365+21 | — | — | — |
| 10 | Suneva Medical Developer of products for the regenerative aesthetic markets | $155M | 50 mo ago | 94 | Pat Altavilla President and Chief Executive Officer | — | — | — | — |
| 11 | Alys Pharmaceuticals Developer of therapeutics for immuno-dermatological conditions | $100M | 28 mo ago | — | Thibaud Portal Founder | — | — | — | — |
| 12 | Lineage Cell Therapeutics Developer of cell based therapies for the treatment of cancer, eye disease and spinal disorders | $94M | 25 mo ago | 75 | Brian Culley CEO | WordPressMySQLPHP+18 | 5 signals ▼64% Earnings | — | — |
| 13 | Cynosure Developer of energy-based aesthetic and medical treatment systems | $87M | 47 mo ago | 669 669 → 827 (+24%) | Michael Davin CEO | WordPressSentryApple iCloud Mail+29 | — | 275 patents Non‑invasive aesthetic medical devices using RF, microwave, and laser for skin tightening and liposuction | — |
| 14 | Cytrellis Developer of aesthetic devices for scar reduction and skin tightening | $86M | 17 mo ago | 59 59 → 59 (+0%) | Jason Richey President & Chief Executive Officer | WordPressApple iCloud MailMySQL+13 | — | — | 1 internship |
| 15 | Forte Biosciences Developer of therapeutic solutions for treating inflammatory skin diseases | $82M | 18 mo ago | 9 | Paul A. Wagner Founder & CEO | Q4MediaElement.jsMicrosoft ASP.NET+13 | 11 signals ▲175% Regulatory · Earnings · IPO | — | — |
| 16 | Aclaris Therapeutics Biopharmaceutical company empowering patients through therapeutic innovation in immuno-inflammatory conditions | $82M | 18 mo ago | 180 | — | DrupalPHPAmazon Web Services+19 | 3 signals ▼86% Earnings | 239 patents Small-molecule kinase inhibitors for dermatologic and immune disorders | — |
| 17 | DermBiont Developer of microbial therapeutics designed to treat skin diseases | $73M | 32 mo ago | 36 | Nichola Eliovits Co-Founder | Squarespace CommerceSquarespaceTypeScript+16 | — | 49 patents Topical PK/AKT inhibitor formulations for treating and preventing skin disorders | — |
| 18 | Pyramid Bio Developer of small molecules for the treatment of dermatology and cancer | $71M | 56 mo ago | 3 | — | — | — | — | — |
| 19 | DeepCure Developer of novel small molecule therapies for immune diseases | $65M | 26 mo ago | — | Thrasyvoulos Karydis Co-Founder & CTO | Cart FunctionalitySquarespace CommerceSquarespace+12 | — | 10 patents AI-driven drug discovery and automated chemical synthesis workflow optimization | — |
| 20 | Xequel Bio Developer of therapeutics for multiple indications | $63M | 16 mo ago | 16 | Jerry Peter CEO | — | — | — | — |
| 21 | Belenos Biosciences Developer of bispecific antibody therapeutics for chronic inflammatory disease treatment | $48M | 23 mo ago | — | Glenn Rosen Co-Founder & Chief Translational Officer | — | — | — | — |
| 22 | NFlection Developer of targeted topical therapies for rare disorders | $45M | 34 mo ago | 6 | Scott Plotkin Co-Founder | — | — | — | — |
| 23 | Histogen Developer of small molecule caspase inhibitors to restore immune function against infectious and inflammatory… | $45M | 47 mo ago | 22 | Gail Naughton Founder & CEO | Cart FunctionalityNode.jsTailwind CSS+13 | — | 97 patents Regenerative cell therapies and anti‑inflammatory biologics using caspase inhibitors and conditioned media | — |
| 24 | Candesant Provider of non-invasive energy device for treating hyperhidrosis | $44M | 36 mo ago | 3 | Niquette Hunt Founder & CEO | — | — | — | — |
| 25 | Siolta Therapeutics Provider of microbiome therapeutics for treating multiple diseases | $42M | 27 mo ago | 14 | Nikole Kimes Founder & CEO | — | — | — | — |
| 26 | VeraDermics Developer of drug-delivery solution for the treatment of pediatric wart treatment | $38M | 8 mo ago | 8 | Kyle Ryder Founder | DrupalPHPAmazon Web Services+21 | 7 signals ▲250% IPO · Capital raise | 76 patents Controlled-release topical minoxidil pharmaceutical formulations for hair growth | 3 job openings · 1 launch |
| 27 | DermaSensor Developer of an AI-powered skin cancer detection device 64Funding top 25%News top 29%Innovation top 35%Growth top 35% All 12 signals ▾Fundingtop 25% Newstop 29% Innovationtop 35% Growthtop 35% AItop 35% Producttop 35% Moattop 37% Techtop 38% Patentstop 42% Talentbottom 49% Marketbottom 34% Globalbottom 33% Funding: Raised $35.8M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) News: 3 BI events in 12 mo (of 7 tracked, 3 types) · Top themes: Funding, Capital raise rank vs industry peers · Fliar Intelligence Index 64/100 | $36M | 8 mo ago | 24 | Cody Simmons CEO | WordPressBetterDocsSentry+46 | 3 signals Funding · Capital raise | 10 patents Non‑invasive optical spectroscopy for melanoma and skin cancer detection | — |
| 28 | Pelage Pharmaceuticals Developer of therapeutics for hair loss treatment in men and women | $31M | 8 mo ago | — | William Lowry Co-Founder & President | WordPressMySQLPHP+19 | 3 signals Funding | — | — |
| 29 | Verrica Pharmaceuticals Developer of therapeutic solutions for skin diseases such as molluscum contagiosum, and others | $27M | 6 mo ago | 40 40 → 85 (+112%) | Ted White President & CEO | WordPressPleskApple iCloud Mail+23 | 4 signals ▼87% Regulatory · Earnings · Leadership | 132 patents Patents concentrated in health & consumer products | — |
| 30 | AVAVA Platform offering intradermal energy solutions for skin treatments | $25M | 3 mo ago | 1 | Irina Erenburg CEO | WordPressApple iCloud MailMicrosoft 365+30 | — | 158 patents Medical laser treatment devices with real-time feedback and motion‑tracking systems | 1 job opening |
| 31 | Indomo Developer of device-enabled therapeutics intended to expand access to quality healthcare | $25M | 7 mo ago | — | Rick Bente Co-Founder & CEO | — | — | — | — |
| 32 | RA Medical systems Developer of xenon chloride excimer lasers for treatment of skin and vascular diseases | $24M | 38 mo ago | 14 | — | — | — | 3,753 patents Medical devices for patient monitoring, vascular occlusion, and cardiac pacing support. | — |
| 33 | One Skin Technologies Developer of a skin therapy product to treat skin aging | $20M | 12 mo ago | 17 | Mariana Boroni Co-Founder | Cart FunctionalityShopifyYouTube+36 | — | — | — |
| 34 | SelectION Provider of screening and development platform for drugs 11Funding top 36%Talent bottom 49%Global bottom 37%Market bottom 17% All 4 signals ▾Fundingtop 36% Talentbottom 49% Globalbottom 37% Marketbottom 17% Funding: Raised $15.9M across 3 rounds · 3 rounds over 7 yrs (0.4/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 11/100 | $16M | 9 mo ago | 2 | Andreas Klostermann Founder & CSO | — | — | — | — |
| 35 | Dermata Therapeutics Developer of therapeutics to treat a variety of dermatologic and ophthalmologic diseases | $16M | 5 mo ago | 8 | Gerry Proehl President & CEO | Squarespace CommerceSquarespaceTypeScript+12 | 5 signals ▼38% Announcements · Leadership | — | — |
| 36 | Alphyn Biologics Developer of therapeutics for severe and common skin diseases 27Patents top 28%Moat top 32%Innovation top 33%Funding top 37% All 7 signals ▾Patentstop 28% Moattop 32% Innovationtop 33% Fundingtop 37% Techbottom 43% Globalbottom 40% Marketbottom 16% Patents: 30 patents matched (strict assignee match) · 21 filings since 2022 vs 9 in 2017-21 Moat: Editorial + unicorn rating 4/10 · IP moat: 30 patents rank vs industry peers · Fliar Intelligence Index 27/100 | $13M | 6 mo ago | 3 | — | WordPressMySQLPHP+22 | — | 25 patents Topical antibacterial skin treatments using croton lechleri-derived pharmaceutical compositions | — |
| 37 | PranaX Provider of regenerative science to treat various health conditions | $10M | 4 mo ago | — | Steven Greco Founder & COO | WebflowGSAPLenis+16 | — | — | — |
| 38 | Aegle Therapeutics Developing extracellular vesicle therapies for debilitating rare diseases and dermatological disorders | $6M | 5 mo ago | 4 | — | WordPressMySQLPHP+16 | — | — | — |
| 39 | Sequential Bio Provider of in-vivio microbiome testing platform for skin care 48Funding top 35%Growth top 35%Talent top 38%Moat top 44% All 7 signals ▾Fundingtop 35% Growthtop 35% Talenttop 38% Moattop 44% Techtop 45% Globaltop 50% Marketbottom 30% Funding: Raised $6.4M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 48/100 | $6M | 3 mo ago | — | Oliver Worsley Co-Founder & CEO | Wix eCommerceWixSentry+17 | — | — | — |
| 40 | Praeventix Developer of novel serotonergic therapeutics for multiple diseases | $4M | 4 mo ago | — | Douglas Pippin Founder & CEO | — | — | 68 patents Novel lactam-based compounds targeting the 5‑HT7 serotonin receptor for therapeutic use | — |
| 41 | Topaz Biosciences Developer of enzyme ingredients for skin microbiome rebalancing | $3M | 10 mo ago | — | Teresa Shock Co-Founder | — | — | — | — |
| 42 | Oasis Pharmaceuticals Developer of therapeutics to treat inflammatory, fibrotic, and metabolic disorders | $2M | 13 mo ago | — | Lidija Covic Founder & CSO | — | — | — | — |
| 43 | Stratum Biosciences Provider of AI-based solutions for dermatological therapies and molecular delivery across the skin 50Talent top 38%AI top 45%Funding bottom 46%Global bottom 33% All 4 signals ▾Talenttop 38% AItop 45% Fundingbottom 46% Globalbottom 33% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated AI: Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 50/100 | $2M | 2 mo ago | — | Ross Pearlman Co-Founder & CEO | — | — | — | 1 partnership · 1 expansion |
| 44 | ResVita Bio Developer of therapies to treat skin diseases through engineered skin probiotics | $2M | 14 mo ago | 4 | Jay Keasling Co-Founder | — | — | — | — |
| 45 | StimuSIL Developer of a therapeutic medical device for dermatology and aesthetics | $2M | 17 mo ago | 7 | Pablo Villalba Co-Founder | — | — | 7 patents Wearable dermal phototherapy devices delivering therapeutic light to skin. | — |
| 46 | Triangulate Labs Computer vision company leveraging 3D mapping technology to aid dermatologists | $2M | 23 mo ago | 6 | John Schneider Co-Founder | — | — | 9 patents Non‑invasive skin imaging and analysis technology. | — |
| 47 | HumanImage Developer of three-dimensional imaging device for skin lesion and cancer tracking | $2M | 2 mo ago | — | David Teplica Founder & CEO & CMO | — | — | 5 patents Three‑dimensional body surface imaging for medical and fitness avatar creation | — |
| 48 | Telomir Pharmaceuticals Developer of a small molecule designed to combat aging and disease | $1M | 12 mo ago | 1 | — | WordPressMySQLPHP+17 | — | — | — |
| 49 | SNC Therapeutics Provider of drug and nonviral gene delivery platform technology for immunotherapy | $250K | 10 mo ago | — | Jeffrey Hubbell Co-Founder | — | — | — | — |
Top 12 Dermatology companies in United States
#1
Public · Sacramento, California · founded 2020 · 33 employees$268Mraised▾
Public · Sacramento, California · founded 2020 · 33 employees
Developer of therapeutic options for chronic inflammatory disorders. The pipeline drug candidates include v for rosacea, and atopic dermatitis, RORγt for psoriasis, MRGPRX2 for pruritus, and PKCϴ for atopic dermatitis. The company uses a tissue-based screening platform that helps in the drug development of inflammatory diseases.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Growth
top 16%Funding
top 18%News
top 25%Tech
top 47%Fin. health
top 47%Moat
top 47%Growth: Revenue +86% YoY · Fresh capital in last 24 mo
Funding: Raised $268M across 6 rounds · 6 rounds over 6 yrs (1.0/yr) · Last round Post IPO (Feb 2026)
News: 15 BI events in 12 mo (of 26 tracked, 6 types) · +650% YoY · 14 high-value events (IPO/M&A/funding/contracts) in 12 mo
Audience (LinkedIn): 5k LinkedIn followers · 58 engagements/post (2.4× cohort median)
Activity (LinkedIn): 2 product launches · 1 partnerships (incl. Maruho Co Ltd.) announced in 12 mo
Funding rounds
- Feb 2026Post IPO$125M
- Oct 2024Series C$115M
- Jun 2023Series B$7.5M
- Mar 2023Series B$57.5M
Investors
Andera Partners, Life Sciences Partners, Pivotal bioVenture Partners, RA Capital Management, Sectoral, RTW Investments
Tech stack
Amazon Web ServicesAosApache Http ServerBootstrapCloudflareCloudflare Bot Management
#2
Public · San Jose, California · founded 2012 · 163 employees$234.1Mraised▾
Public · San Jose, California · founded 2012 · 163 employees
Developer of technology for the oral delivery of large drug molecules. The company has a proprietary platform is capable of delivering a wide range of biologics for the treatment of various chronic diseases. The company develops RaniPill capsule has broad applications for the treatment of acromegaly, rheumatoid arthritis, psoriatic arthritis, growth hormone deficiency, osteoporosis, Crohn’s disease, hemophilia, diabetes, among other diseases.
Fliar Intelligence Index™ 72how this company ranks against its industry peers
Growth
top 22%Funding
top 23%Patents
top 24%Talent
top 27%Innovation
top 28%News
top 30%Growth: Revenue +59% YoY · Fresh capital in last 24 mo
Funding: Raised $234M across 6 rounds · 6 rounds over 13 yrs (0.5/yr) · Last round Post IPO (Oct 2025)
Patents: 456 patents matched (strict assignee match) · 180 filings since 2022 vs 204 in 2017-21 · Latest publication 2026
Audience (LinkedIn): 6k LinkedIn followers
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Oct 2025Post IPO$60.3M
- Dec 2020Series E$69M
- Nov 2020Series E$50M
- Feb 2018Series E$53M
Founders & team
Investors
GeneScience Pharmaceuticals, Shire, Cathay Financial Holdings, Google Ventures, Novartis, AstraZeneca
Tech stack
Acquia Cloud PlatformAcquia Cloud Site FactoryAdobe AnalyticsAdobe Experience Platform Identity ServiceAdobe Experience Platform LaunchAkamai
#3
Series B · Waltham, Massachusetts · founded 2016 · 1 employees$25.2Mraised▾
Series B · Waltham, Massachusetts · founded 2016 · 1 employees
Platform offering intradermal energy solutions for skin treatments. It provides aesthetic treatments aim to address skin pigmentation issues and rejuvenate skin color. It utilize imaging and artificial intelligence to create personalized treatment plans for patients.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers
Hiring: 1 hiring post in 12 mo (public) · hiring: Production Supervisor
Funding rounds
- Feb 2026Series B$19.6M
- Apr 2024Series B$25.2M
Founders & team
Tech stack
AkismetAmazon Web ServicesApple Icloud MailCdnjsCloudflareCloudflare Bot Management
#4
Public · San Diego, California · founded 2014 · 8 employees$15.7Mraised▾
Public · San Diego, California · founded 2014 · 8 employees
Developer of therapeutics to treat a variety of dermatologic and ophthalmologic diseases. It offer XYNGARI a topical treatment derived from freshwater sponge extract targeting moderate‑to‑severe acne, with potential in psoriasis and rosacea and DMT410 a topical intradermal delivery system allowing botulinum toxin to penetrate via microchannels for aesthetic and medical skin treatments.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 916 LinkedIn followers
Activity: 1 product launches announced in 12 mo
Funding rounds
- Dec 2025Post IPO$4.1M
- Jan 2025Post IPO$2.5M
- Sep 2024Post IPO$3.5M
- May 2023Post IPO—
Founders & team
Investors
SVB, H.C. Wainwright
Tech stack
AngularCore-JsGodaddyHstsMicrosoft 365Modernizr
#5
Public · West Chester, Pennsylvania · founded 2013 · 40 employees$27.4Mraised▾
Public · West Chester, Pennsylvania · founded 2013 · 40 employees
Verrica is a developer of therapeutic solutions for skin diseases such as molluscum contagiosum, and others. It has developed a lead product, VP-100 is a topical film forming formulation, indicated for molluscum contagiosum and Verruca Vulgaris (common warts and plantar warts). VP-100 has completed phase II trials and the company is initiating pivotal phase III trials for Molluscum contagiosum. The company is also developing treatments for additional common dermal indications including Actinic Keratosis and Seborrheic Keratosis.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 15k LinkedIn followers — 4.1% of this cohort's audience
Funding rounds
- Nov 2025Post IPO$50M
- Feb 2018Series B$20M
- Dec 2017Series A$5M
- Dec 2015Series A$2.4M
Founders & team
Investors
Pharus, Perceptive Advisors, Westwicke, Orbimed, PBM Capital, avenuealtd.com
Tech stack
Apple Icloud MailCloudflareCloudflare Browser InsightsCore-JsElementorFont Awesome
#6
Public · San Antonio, Texas · founded 2020 · 8 employees$37.7Mraised▾
Public · San Antonio, Texas · founded 2020 · 8 employees
Developer of drug-delivery solution for the treatment of pediatric wart treatment. The company's proprietary product WartPatch is a drug delivery platform for kids for the treatment of dermatological problems.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers · 77 engagements/post (3.2× cohort median)
Hiring: 3 hiring posts in 12 mo (public) · momentum +3 · hiring: Senior Director, Business Insights & Competitive Intelligence, Senior Director, Commercial Operations & Strategic Analytics
Activity: 1 product launches announced in 12 mo
Funding rounds
- Oct 2025Series C$150M
- Dec 2024Series B$75M
- May 2023Series B$15M
- Sep 2021Series A$22.2M
Founders & team
Investors
Prospect Hill Growth Partners, Connecticut Innovations, Suvretta Capital Management, Longitude Capital, Citadel, Osage University Partners
Tech stack
AccessibeAcquia Cloud PlatformAcquia Cloud Site FactoryAdobe AnalyticsAdobe Experience Platform Identity ServiceAdobe Experience Platform Launch
#7
Series B · Miami, Florida · founded 2009 · 24 employees$35.8Mraised▾
Series B · Miami, Florida · founded 2009 · 24 employees
Developer of an AI-powered skin cancer detection device. The company offers DermaSensor device that uses a combination of cutting-edge optical spectroscopy and artificial intelligence to promptly analyze suspicious skin lesions. The device shines light bursts on a lesion, captures scattered light spectra, and uses proprietary AI algorithms to assess malignancy risk for melanoma, basal cell carcinoma, and squamous cell carcinoma.
Fliar Intelligence Index™ 64how this company ranks against its industry peers
Funding
top 25%News
top 29%Innovation
top 35%Growth
top 35%AI
top 35%Product
top 35%Funding: Raised $35.8M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) · Last round Series B (Oct 2025)
News: 3 BI events in 12 mo (of 7 tracked, 3 types) · Top themes: Funding, Capital raise
Innovation: 10 patents (top 62% of patent-holders) · 7 filings since 2022 vs 2 in 2017-21 · 3 product lines
Audience (LinkedIn): 6k LinkedIn followers
Funding rounds
- Oct 2025Series B$16M
- Nov 2024Series B$8.9M
- Jun 2022Series B$10M
- Dec 2021Series A$8.5M
Founders & team
Investors
Ceros Capital Markets, SternAegis Ventures, Miami Angels, Pier 70 Ventures, Kern Venture Group, GenHenn Capital
Tech stack
Amazon Web ServicesAnime.JsApache Http ServerApple Icloud MailAstraAws Certificate Manager
#8
Series A · New York City, New York · founded 2019$6.4Mraised▾
Series A · New York City, New York · founded 2019
Provider of in-vivio microbiome testing platform for skin care. The company offers at-home skin microbiome tests, through the Sequential Skin patch for skin care, scalp care, intimate care, or oral care.
Fliar Intelligence Index™ 48how this company ranks against its industry peers
Funding
top 35%Growth
top 35%Talent
top 38%Moat
top 44%Tech
top 45%Global
top 50%Funding: Raised $6.4M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) · Last round Series A (Mar 2026)
Growth: Fresh capital in last 24 mo
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding rounds
- Mar 2026Series A$3.5M
- May 2023Seed—
- Oct 2022Seed$500K
- Jun 2022Grant (prize money)$500K
Founders & team
Investors
Sparkfood, Corundum Systems Biology, SOSV, Scrum Ventures, Ukri, IndieBio
Tech stack
BootstrapCloudflareCloudflare Bot ManagementCore-JsGoogle AnalyticsGoogle Cloud
#9
Series B · Annapolis, Maryland · founded 2019 · 3 employees$12.6Mraised▾
Series B · Annapolis, Maryland · founded 2019 · 3 employees
Developer of therapeutics for severe and common skin diseases. The lead candidate of the company AB-101 is the topical drug to treat skin infections caused by MRSA bacteria, Pseudomonas, and other multi-drug resistant organisms (MDOs). The substance AB-101 is generated by an available tropical plant as its own defense against bacteria.
Fliar Intelligence Index™ 27how this company ranks against its industry peers
Patents
top 28%Moat
top 32%Innovation
top 33%Funding
top 37%Tech
bottom 43%Global
bottom 40%Patents: 30 patents matched (strict assignee match) · 21 filings since 2022 vs 9 in 2017-21 · Latest publication 2025
Moat: Editorial + unicorn rating 4/10 · IP moat: 30 patents
Innovation: 30 patents (top 42% of patent-holders) · 21 filings since 2022 vs 9 in 2017-21
Audience (LinkedIn): 908 LinkedIn followers
Funding rounds
- Dec 2025Series B$25M
- Mar 2024Series B$5.2M
- May 2023Series A$1.2M
- Sep 2022Series A$3.3M
Investors
Queen City Angels, Angel Physicians Fund, Serial Stage Venture Partners
Tech stack
Animate.CssCloudflareCloudflare Bot ManagementContact Form 7Core-JsGodaddy
#10
Series A · Houston, Texas · founded 2022$10Mraised▾
Series A · Houston, Texas · founded 2022
Provider of regenerative science to treat various health conditions. The company is developing exosomes as anti-aging supplements to establish stem-cell derived exosomes for tissue repair and organ regeneration.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Funding rounds
- Jan 2026Series A$17M
- Dec 2023Series A$10M
Founders & team
Tech stack
CloudflareCloudflare Bot ManagementCore-JsGoogle AnalyticsGoogle Font ApiGoogle Hosted Libraries
#11
Series B · Los Angeles, California · founded 2018$30.8Mraised▾
Series B · Los Angeles, California · founded 2018
Developer of therapeutics for hair loss treatment in men and women. It provides a topical, non-invasive small molecule pharmacological platform that can be used to activate hair follicle stem cells and promote thick hair growth.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Activity: 1 product launches announced in 12 mo
Funding rounds
- Sep 2025Series B$120M
- Aug 2024Series A$14M
- Feb 2024Series A$16.8M
Founders & team
Investors
Google Ventures, Main Street Advisors, Visionary Ventures, Arch Venture Partners, Ykbioventures.com
Tech stack
Anime.JsCloudflareCloudflare Bot ManagementCore-JsElementorGodaddy
#12
Series B · San Francisco, California · founded 2021$25Mraised▾
Series B · San Francisco, California · founded 2021
Developer of device-enabled therapeutics intended to expand access to quality healthcare. The company focuses on creating fast-acting, at-home solutions for inflammatory skin conditions. It combines drug candidates with novel intradermal self-injection devices. The goal is to empower patients to perform treatments safely at home.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 439 LinkedIn followers
Hiring: 1 hiring post in 12 mo (public) · hiring: Drug CMC Lead
Activity: 2 product launches · 1 partnerships (incl. WWD) announced in 12 mo
Funding rounds
- Oct 2025Series B$25M
Founders & team
Investors
Atomic, Foresite Capital, Polaris Partners
Funding & investor landscape
$7.4Btotal disclosed funding
191companies funded
711disclosed rounds
3rounds last 90 days
Most active investors
New Enterprise Associates5 rounds
Notable founders
Mir Imran
Founder · Rani Therapeutics
Talat Imran
CEO · Rani Therapeutics
Irina Erenburg
CEO · AVAVA
Gerry Proehl
President & CEO · Dermata Therapeutics
Ted White
President & CEO · Verrica Pharmaceuticals
Kyle Ryder
Founder · VeraDermics
Cody Simmons
CEO · DermaSensor
Oliver Worsley
Co-Founder & CEO · Sequential Bio
Albert Dashi
Co-Founder · Sequential Bio
Steven Greco
Founder & COO · PranaX
William Lowry
Co-Founder & President · Pelage Pharmaceuticals
Heather Christofk
Co-Founder · Pelage Pharmaceuticals
Prism market signals · United States · country-scoped Prism corpus, 11,111,593 docs
Market landscape — 10 sub-themes by coverage
Share of Dermatology coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
How many Dermatology companies are there in United States?
Radar tracks 390 indexable Dermatology companies headquartered in United States that meet our profile-completeness bar.
What is the total funding raised by Dermatology companies in United States?
The Dermatology companies in United States on this list have raised a combined $7.4B in disclosed equity funding across 191 funded companies.
Which is the highest-funded Dermatology company in United States?
Incyte is the highest-funded Dermatology company in United States, with $750M in disclosed equity funding.
How many Dermatology companies in United States are funded?
191 of the 390 Dermatology companies in United States on this list have disclosed at least one equity funding round.
How many Dermatology unicorns are there in United States?
None of the Dermatology companies in United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in United States Dermatology companies?
The most active investors in United States Dermatology companies on this list include HHS, Aisling Capital, Orbimed, Polaris Partners, Arch Venture Partners.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.